InvestorsHub Logo
icon url

Pharma Sleuth

02/20/24 5:40 PM

#396579 RE: namtae #396578

What is the current P/E and how many drugs pending approval? What is the current trajectory of just the approved drugs and revenue?

Are you not allowed to answer?
icon url

Pharma Sleuth

02/20/24 5:44 PM

#396580 RE: namtae #396578

Ok. Let's assume you don't know why you are here and you are not allowed to answer.

What would be the reasons you were assigned to be here?

Someone is very very short on the stock and requires your presence on this board.

Someone is looking to acquire the company.

Now both of these can actually be true to some extent. Which do you think is more likely?
icon url

Pharma Sleuth

02/20/24 5:51 PM

#396581 RE: namtae #396578

Here is your overall problem. The company is in a rapid growth phase (see the revenue chart) but the biggest products are in the near term future. So you have rapid growth on just the currently approved products and an already low P/E.

Then you have multiple products pending approval now.

What does this mean? It means that this is about as safe an investment as you can find.

Note I said investment. People trade and that's cool too. No issue there.
icon url

NASDAQ2020

02/20/24 6:43 PM

#396584 RE: namtae #396578

COVID’s over now
icon url

The ELTP King

02/21/24 2:12 AM

#396604 RE: namtae #396578

Exactly. And I remember the exact quote too.

Nasrat is so full of sh*t.

He knows he's lying too. He just doesn't care.

The CEO was talking nasdaq within 2 years way back in 2017 or so